Clinical course of obstructive jaundice associated with operated meconium peritonitis in neonates

K Sakai1, S Ono, S Fumino

  • 1Department of Pediatric Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Abstract

Insights

Meconium peritonitis (MP) can cause prolonged jaundice in infants. Most cases resolve with conservative treatment, but imaging is crucial to rule out biliary atresia (BA) in persistent cases.

Area of Science:

  • Pediatric Surgery
  • Neonatal Gastroenterology
  • Hepatology

Background:

  • Meconium peritonitis (MP) is a rare neonatal condition that can lead to prolonged cholestasis post-laparotomy.
  • Obstructive jaundice, including biliary atresia (BA), is a potential complication in infants with MP.

Purpose of the Study:

  • To retrospectively analyze the clinical course of infants with MP.
  • To investigate the association between MP and the development of obstructive jaundice.
  • To differentiate MP-associated jaundice from biliary atresia (BA).

Main Methods:

  • Retrospective review of 23 infants with MP who underwent laparotomy between 1979 and 2008.
  • Analysis of clinical data for 11 infants who developed postoperative obstructive jaundice.
  • Utilized ultrasonography, HIDA scintigraphy, and open cholangiography for diagnosis.

Main Results:

  • Of 23 infants with MP, 11 (47.8%) developed obstructive jaundice.
  • Jejunoileal atresia was the underlying cause in 10 infants; cloacal anomaly in 1.
  • Nine of 11 infants improved with conservative management; 2 required further investigation for BA.

Conclusions:

  • Postoperative cholestasis following meconium peritonitis is typically transient.
  • Ultrasonography and HIDA scintigraphy are essential to differentiate BA in infants with MP and prolonged jaundice with acholic stools.

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Intestinal Obstruction II: Pathophysiology01:07

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...